Testing a new version of an oral medication for healthy adults
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This study tests whether a new version of a medication (AJU-R713) is absorbed into the body the same way as the original (R713R). It's for healthy adults who want to help evaluate the safety and how the body handles the drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years old or older.
- Your body mass index (BMI) must be between 18 and 30.
- You must be in good general health, with no major medical problems.
- You cannot be pregnant, breastfeeding, or planning to become pregnant during the study.
- You must agree to use effective non-hormonal birth control if you or your partner could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an oral tablet (HSK31858) to see if it helps control asthma in people whose asthma is not well managed with current inhalers. It focuses on those with a specific type of asthma where certain blood cells are low.
This study tests whether two different formulations of an experimental medication (AJU-C715) work the same way in your body. Researchers will give you one version and then later the other version to compare how much of the drug enters your bloodstream and how long it stays there.
This study tests whether two versions of the same medication (AJU-G721 and G721R)—used to treat hair loss and urinary symptoms—work the same way in the body. Researchers will measure how much medication gets absorbed and how long it stays in your system.
This study tests whether two formulations of a prostate medication (AJU-G721 and G721R) work the same way in your body. Researchers give both versions to healthy volunteers to make sure they're equally effective and safe.
This study tests an investigational drug called PRA-216, first in healthy volunteers to check safety, then in people with mild-to-moderate asthma to see if it helps control symptoms. It's an early-stage trial to find out if the drug is safe and works.
This study tests different doses of a new medicine (PF-08103402) to see how well it is tolerated and how it works in both healthy adults and adults with mild to moderate asthma. It helps researchers find the right dose for future studies.
Hear when a new Bronchial Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.